B
Bioliberty
United Kingdom · Healthtech · Robotics
Soft robotics and therapy software for rehabilitation after neurological injury.
Product
Bioliberty develops soft robotics and software to help physical and occupational therapists deliver repetitive rehabilitation following stroke and other neurological conditions. Its technology combines assisted hand movement with interactive exercises.
The system captures therapy data so clinicians can track progress and adjust treatment. The Edinburgh company serves rehabilitation providers and is developing technology to connect care across clinical and home settings.
Funding history
3 rounds · 3 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A extension | $3.3M | 25m Health — ParticipantBallad Ventures — ParticipantTGH Ventures — ParticipantWhiterock — Participant | |
| Series A initial close | £6.2M | Scottish National Investment Bank — LeadArchangels — ParticipantConduit Connect — ParticipantEos Advisory — ParticipantHanna Capital SEZC — ParticipantOld College Capital — Participant | |
| Pre-Series A | £1.5M | Archangels — ParticipantEos Advisory — ParticipantHanna Capital SEZC — ParticipantOld College Capital — Participant |
Investors
25m HealthJoined Series A extensionBallad VenturesJoined Series A extensionTGH VenturesJoined Series A extensionWhiterockJoined Series A extensionScottish National Investment BankLed Series A initial closeArchangelsJoined Series A initial close · Joined Pre-Series AConduit ConnectJoined Series A initial closeEos AdvisoryJoined Series A initial close · Joined Pre-Series AHanna Capital SEZCJoined Series A initial close · Joined Pre-Series AOld College CapitalJoined Series A initial close · Joined Pre-Series ACoverage
Nov 2, 2026Bioliberty · Series A extensionMar 18, 2026Bioliberty · Series A initial closeJun 21, 2025Bioliberty · Pre-Series ASimilar companies
Human Physical IntelligenceHuman Physical Intelligence develops AI-controlled assist suits that help care workers learn and maintain less physically demanding working postures.¥10M · Japan Finance Corporation startup loan
MTMucoLife TherapeuticsDeveloping inhaled peptide medicines to clear mucus obstructions in lung disease.SEK 1M · Vinnova ScaleGla grant
PPhysiclSynthetic 3D environments and labelled training data for robotics and world models.$10M · Seed